Quillivant XR 25 MG/5 ML susp 60ML
Ended Awarded
- Contract number
- SPE2DX25F6PLT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,915
Award facts
- Contract value 100% obligated
- $2,915.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml quantities, valued at $2,915.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this order draws from AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's role under the DLA Medical Supply Chain encompasses a broad portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. Quillivant XR is an extended-release stimulant medication used in attention deficit hyperactivity disorder treatment, representing one component of the company's diverse pharmaceutical support to defense healthcare programs. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across varying transaction sizes demonstrates its established capability to meet federal procurement requirements efficiently.
Quick answers
Who was awarded contract SPE2DX25F6PLT?
SPE2DX25F6PLT was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on June 2, 2025.
How much is contract SPE2DX25F6PLT worth?
The government has obligated $2,915 on SPE2DX25F6PLT.
Is contract SPE2DX25F6PLT an order under another contract?
Yes. SPE2DX25F6PLT is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6PLT competed?
The extent of competition for SPE2DX25F6PLT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award